Inhibitory dysfunction and social processing difficulties in autism: A comprehensive narrative review.

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter, crucial for neural development and function.
• Disruptions in GABAergic signaling are associated with neurodevelopmental disorders, especially autism spectrum disorder (ASD).
• Imbalances in excitation-inhibition can lead to social processing deficits characteristic of ASD.

Purpose of the Study:

• To review the role of inhibitory dysfunction in autism.
• To focus on the link between GABAergic signaling and social processing difficulties in autism.
• To explore potential psychopharmacological interventions targeting GABA.

Main Methods:

• Comprehensive narrative review of interdisciplinary research.
• Integration of findings from molecular neurobiology, genetics, epigenetics, and systems neuroscience.
• Analysis of studies on neurotransmitter levels (GABA, glutamate) and their relation to autism symptoms.

Main Results:

• Social processing difficulties in autism are often linked to elevated glutamate and/or reduced GABA levels.
• Early developmental neurochemical disruptions can impact neuronal circuit balance.
• GABA modulation shows potential as a therapeutic strategy for social deficits.

Conclusions:

• Inhibitory dysfunction, particularly involving GABA, is relevant to autism's core social deficits.
• Understanding GABAergic mechanisms offers insights into autism pathophysiology.
• GABA-targeting psychopharmacology may provide novel treatments for social difficulties in autism.